FDA Stresses Need For Drug Trials Involving Children

Posted on August 26, 2013

The Food and Drug Administration is taking steps to ensure that studies designed to determine whether or not certain drugs would be safe for children are carried out in a safe and efficient manner.  Thanks to Congress’s recent reauthorization of the Pediatric Research Equity Act, the FDA is now able to extend the deadline by which researchers are supposed to complete a given study if they determine that the request is being made for acceptable reasons.  This may occur for a variety of reasons, such as the researchers not having enough patients to carry out an adequate study.  This also gives the FDA the power to call out the companies that haven’t complied with a set deadline.  In a new report, the FDA explains how they’re trying to make sure that drug safety continues to be boosted among children, something that can only be done by testing how kids would react to certain drugs.

Follow this link for more about the FDA’s efforts.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.
*Required Fields